Candelanza, Cristine M.

HRN: 14-01-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
CEFAZOLIN 1GM (VIAL)
09/18/2025
09/18/2025
IVTT
2g
PTOR
Ectopic Pregnancy Ruptured
Checking Initial Appropriateness 
09/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/18/2025
09/25/2025
IV
600 Mg
Every 6 Hours
S/P Pelvic Lap With BTL
Checking Initial Appropriateness 
09/18/2025
CLINDAMYCIN 300MG (CAP)
09/18/2025
09/24/2025
PO
300mg
TID
SP Pelvic Lap With BTL
Checking Initial Appropriateness 
09/18/2025
MUPIROCIN 2%, 15G (TUBE)
09/18/2025
09/24/2025
TOPICAL
1ml
BID
SP Pelvic Lap With BTL
Checking Initial Appropriateness 
09/20/2025
MUPIROCIN 2%, 15G (TUBE)
09/20/2025
09/27/2025
TOPICAL
Apply On Affected Area
BID
SP Pelvic Lap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: